If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rita Danesi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
irinotecan Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Dihydrouracil Dehydrogenase (NADP) Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences
Clinical Pharmacology Medicine & Life Sciences
Alleles Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 50 Citations
  • 5 h-Index
  • 6 Article
  • 2 Review article
1 Citation (Scopus)

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients

Del Re, M., Cinieri, S., Michelucci, A., Salvadori, S., Loupakis, F., Schirripa, M., Cremolini, C., Crucitta, S., Barbara, C., Di Leo, A., Latiano, T. P., Pietrantonio, F., Di Donato, S., Simi, P., Passardi, A., De Braud, F., Altavilla, G., Zamagni, C., Bordonaro, R., Butera, A. & 6 others, Maiello, E., Pinto, C., Falcone, A., Mazzotti, V., Morganti, R. & Danesi, R., Jan 1 2019, In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Dihydrouracil Dehydrogenase (NADP)
Drug-Related Side Effects and Adverse Reactions
Neutropenia
Real-Time Polymerase Chain Reaction
1 Citation (Scopus)

Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology

Finocchiaro, C. Y., Rota, A., Barbieri, V., Bettini, A., Bianco, R., Borra, G., Buffoni, L., Bulotta, A., Carta, A., Cortinovis, D., Costanzo, R., Cusmai, A., Danesi, R., D'Argento, E., Del Conte, A., Franchina, T., Gilli, M., Gregorc, V., Irtelli, L., Landi, L. & 18 others, Malorgio, F., Mancuso, G., Martelli, O., Mazzanti, P., Melotti, B., Migliorino, M. R., Minotti, V., Montrone, M., Morabito, A., Roca, E., Romano, G., Rossi, A., Savio, G., Tiseo, M., Boscardini, I., Piccolo, L., Pilotto, S. & Malapelle, U., Jan 1 2019, In : Translational Cancer Research. 8, p. S16-S22

Research output: Contribution to journalArticle

Thorax
Communication
Social Media
Internet
Manual Communication
8 Citations (Scopus)

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer

Cremolini, C., Del Re, M., Antoniotti, C., Lonardi, S., Bergamo, F., Loupakis, F., Borelli, B., Marmorino, F., Citi, V., Cortesi, E., Moretto, R., Ronzoni, M., Tomasello, G., Zaniboni, A., Racca, P., Buonadonna, A., Allegrini, G., Ricci, V., Di Donato, S., Zagonel, V. & 3 others, Boni, L., Falcone, A. & Danesi, R., Jan 1 2018, In : Oncotarget. 9, 8, p. 7859-7866 8 p.

Research output: Contribution to journalArticle

irinotecan
Colorectal Neoplasms
Fluorouracil
Genotype
Stomatitis
5 Citations (Scopus)

EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance

Fogli, S., Polini, B., Del Re, M., Petrini, I., Passaro, A., Crucitta, S., Rofi, E. & Danesi, R., Jan 1 2018, In : Pharmacogenomics. 19, 8, p. 727-740 14 p.

Research output: Contribution to journalReview article

Clinical Pharmacology
Non-Small Cell Lung Carcinoma
Pharmacology
Therapeutics
Treatment Failure
5 Citations (Scopus)

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper

Cuneo, A., Barosi, G., Danesi, R., Fagiuoli, S., Ghia, P., Marzano, A., Montillo, M., Poletti, V., Viale, P. & Zinzani, P. L., Jan 1 2018, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Therapeutics
idelalisib
Colitis